Investigations in recent years have demonstrated that clinical influenza may be caused by at least two serologically specific filtrable viruses (1 to 6). It is probable that other etiologic agents will be discovered. The clinical characteristics of influenza caused by different agents are exceedingly uniform and no accurate method of distinguishing them by clinical means has been found (6 to 10). The etiologic diagnosis of influenza must at present rest upon discovery of the virus responsible in the throat washings from ill patients or upon detection of a rise of specific antibodies in the blood during convalescence. Antibody studies by means of complement fixation or neutralization tests have been found reliable in indicating infection with the known viruses (11, 13, 14) . On the basis of etiology, a classification of influenza has been suggested (11, 12) . Influenza A will indicate the disease caused by the virus isolated by Smith, Andrewes and Laidlaw in 1933, subsequently termed human influenza virus, epidemic influenza virus and now influenza virus A. Since 1933 many strains of this virus have been found in association with widespread outbreaks of influenza in many parts of the world which have occurred at intervals of about two years (6 to 11). In 1940, Francis (3, 6) and Magill (4, 5) isolated a virus which was antigenically dissimilar from virus A and proved it to be the cause of outbreaks of influenza in the United States in that year. Influenza B indicates the disease caused by this virus. Francis has shown that the epidemic of 1936 in California and elsewhere in the United States was influenza B. The cases of clinical influenza for which no etiology can be established by appropriate tests are designated influenza X. Several undiscovered virus agents may be included in this group.
The knowledge that influenza comprises a group of clinically similar diseases caused by several serologically distinct viruses is of epidemiological significance, especially when the problem of prevention by vaccination is considered. It seems important to study carefully epidemics of influenza in the hope of developing means of early differentiation of types and of establishing the cause of each epidemic either by isolation of the virus or serological tests. We present observations made during an epidemic of influenza A which occurred in San Francisco in November and December 1940 and January 1941. The clinical features of the disease and the results of prophylactic inoculation against influenza A are described. The results were controlled by antibody studies on many individuals.
METHOD
Blood specimens were taken during the acute stage and again two to three weeks later from 70 patients with clinical influenza who were admitted to the University of California Hospital. Complement fixation tests against influenza A were done on all specimens and neutralization tests on most of them. Neutralization tests with influenza B were made on the serums of all patients whose specimens failed to reveal a rise in antibodies to influenza A. The methods used have been described in detail elsewhere (13, 14, 18 Superscripts indicate number of days after inoculation when onset of influenza occurred.
RESULTS OF INOCULATION WITH VACCINE
A total of 273 individuals of the Medical Center population was inoculated with the complex vaccine of Horsfall and Lennette. The injections were made on November 26 and 28 and December 3. The epidemic was in progress a few days before the first inoculations were carried out.
No significant reactions occurred following injection. Tenderness over the injected site, which persisted three to four days without redness or swelling, was a common experience. A few individuals had slight redness and swelling of the arm for twenty-four hours. One individual had generalized urticaria three days after injection and another had mild urticaria seven days afterwards. One experienced an erythematous eruption with swelling of hands, feet, and lips on the fifth day. Another suffered from rhinitis and sneezing for twelve hours beginning one hour after inoculation. None of these individuals had a history of allergic disease.
The incidence of influenza in vaccinated and control groups was compared (Table II) Table II was much higher in the hospital control group than in the general control group, either because of better observation or because of greater exposure. The unvaccinated student group could be observed only if the individual members reported illness to the student infirmary. The Christmas holiday began during the decline in incidence of cases of influenza and the students left the institution during this period. Consequently, the incidence presented for the student group is inaccurate. The only figures in the survey subject to a significant error are those relative to the incidence among the general campus population, especially in the student group, who were not inoculated; all inoculated persons and the hospital staff group were observed. The general incidence of influenza at the Medical Center must have been higher than 25 per cent. Therefore, the difference in incidence between vaccinated and control groups is probably greater than that presented for the total population and may be more accurately represented by the experience of the hospital staff group. Antibody studies were made on acute and convalescent blood specimens from patients of both groups. Fifty control and 20 vaccinated subjects who had influenza were studied. Forty-two (84 per cent) of the controls and 11 (55 per cent) of those inoculated showed significant rises in antibodies to influenza A and were considered positive for influenza A (Table III) . This further reduces the incidence of influenza A in the vaccinated group as compared to the controls.
Since influenza A appeared before vaccination was carried out, the days of onset must be compared in order to evaluate the effect of vaccination. Only established cases of influenza A will be considered. Table I shows the general incidence by weeks and indicates both control and vaccinated subjects. The number of days after inoculation when influenza A occurred in vaccinated persons are demonstrated in Table I by superscripts.
Of those inoculated who subsequently had influenza, only 4 were shown to have acquired influenza A more than ten days after inoculation. In 2 of these the disease developed twenty-three and thirty-nine days, respectively, and each devel- oped significant increases in titer of both complement fixing and neutralizing antibodies during the disease. These 2 cases show clearly that vaccination did not afford certain protection. Table I shows that the incidence of influenza A in the epidemic reached its peak during the ten days after vaccination and then rapidly subsided in the population as a whole during the time when vaccination might be expected to become effective. It is unfortunate that the experiment was not begun sooner. However, the difference in incidence of influenza A in the vaccinated as compared to the control group is striking and may be due to a protective effect of vaccination which began sooner after inoculation than is usually considered likely.
CLINICAL FEATURES
The clinical characteristics described are based on the observation of patients in the hospital who were subsequently shown to have suffered from either influenza A, or neither influenza A nor B, as established by antibody studies. As indicated be-fore, this group consisted of 70 persons, 53 of whom had influenza A and 17 neither influenza A nor B. Of these, 20 had been previously vaccinated and the characteristics of influenza A in them are also considered. Table IV t Complicated by atypical pneumonia.
than those with influenza of unknown etiology.
The maximum leukocyte counts as tabulated show little difference between the groups. Maximum counts were below 7,000 per cubic millimeter in 63.4 per cent and below 10,000 per cubic millimeter in 86 per cent of the cases of influenza A. Pulmonary complications occurred in 2 patients, both of whom were shown to have had influenza A. Pneumococcus Type IV lobar pneumonia developed in a 20-year-old student nurse after four days of fever with clinical and serological evidence of influenza A beginning December 19. Blood culture was negative. The patient recovered during sulfathiazole therapy. She had been inoculated with vaccine twenty-three days prior to onset of influenza A. At the onset of pneumonia, her leukocyte count increased from 5,600 to 20,000 per cubic millimeter. The second patient was a 27-year-old dental student who had evidence of atypical pneumonia in both lung bases on the fourth day of fever in the course of influenza A which had begun on December 6. He experienced a total febrile period of twelve days. The leukocyte count rose from 6,100 to 11,000 per cubic millimeter on the seventh day, to 16,470 per cubic millimeter on the tenth day. No causative organism was discovered in sputum or blood and no effect on the course was observed during the exhibition of sulfathiazole. It is probable that this patient had atypical pneumonia of virus etiology, possibly due to the virus of influenza A. He also made an uneventful recovery. He had not been inoculated with vaccine. The characteristics of influenza A observed during this epidemic were similar to those in epidemics previously described (7, 8, 25) . The disease was of moderate severity, the incidence of pulmonary complications was low, and no deaths occurred. We did not find it possible to distinguish clinically between influenza A and influenza of unknown etiology which occurred during the same epidemic. There was no evidence that the disease was modified in persons who had previously received a prophylactic inoculation. Subclinical infection may have influenced the results of antibody studies. This was not determined. DISCUSSION Since influenza of known etiology has been divided into two types, A and B, each caused by a different virus agent, much of the confusion concerning the epidemiology of the group of diseases called influenza has been dispelled. That all cases of influenza are not caused by known agents seems clear. Influenza X may represent a variety of agents of virus or possibly other nature. In the group reported, a high proportion of cases were influenza A. Nevertheless, a definite proportion of cases appeared simultaneously on which tests failed to reveal evidence of infection with either virus A or B. An analysis of these cases failed to reveal an accurate clinical method of differentiation. All were clinical influenza, appearing and disappearing at the same time. Therefore, influenza A and a febrile respiratory disease of unknown etiology occurred together in this epidemic. Influenza B was not discovered.
Since the discovery of the virus etiology of one form of influenza (1), studies on the effectiveness of vaccination with active and inactive virus have been made in animals and humans (19 to 30). The parenteral inoculations of both active and inactive material by either single or multiple injections have been made by the intraperitoneal, intramuscular, subcutaneous and intradermal routes. In ferrets, mice and humans, rises in antibodies have been induced by vaccination. In ferrets and mice relative immunity has developed to subsequent infection which is to a great extent strainspecific and which persists three to four months (16, 17, 19, 22, 27 (24, 25) , virus was obtained from patients who had been previously vaccinated. Recent inoculation experiments with the complex vaccine of Horsfall and Lennette have given some evidence that a protective effect against influenza A was obtained (30) . In another study in California during the recent epidemic of influenza A, the formalininactivated complex vaccine and a living vaccine of influenza A virus appeared to give comparable results. The results were suggestive of a protective effect against influenza A after inoculation with either preparation at one institution but were questionable at another (29) .
The observations we present are also difficult to evaluate and do not give conclusive evidence of protection against influenza A by vaccination. This was due to the presence of cases of influenza A in the community before inoculations were begun and to the fact that the peak incidence was reached within ten days after inoculation of most individuals. Furthermore, two vaccinated individuals acquired influenza A twenty-three and thirty-nine days, respectively, after inoculation. However, the incidence of influenza in vaccinated individuals was markedly less than in the controls. In addition, the disease which occurred in vaccinated persons was proved to be influenza A by antibody studies in a much smaller percentage of those inoculated than among the control. group. The definite difference in incidence of disease between inoculated persons and controls is difficult to explain unless we assume that some protection was afforded by the vaccine. If this occurred, the vaccine must have produced an immunity earlier after inoculation than is usually considered possible and at a time when measurable protective antibodies are absent or just beginning to rise in the blood. The factors of age, nutrition and previous exposure to influenza A may be of significance in determining the speed with which antibody formation occurs and protection develops.
These factors may also explain differences in results of vaccination of different groups with the same vaccine. The other alternative in the present study is to consider that the inoculated group escaped infection by chance, which is, however, statistically unlikely. 2. Antibody studies indicated that influenza A was the causative agent in 75 per cent of the cases.
There was no evidence of the presence of influenza B.
3. Subcutaneous inoculation of 273 of a total of 1213 individuals was performed with a mixed influenza A-distemper vaccine. A marked reduction in incidence of influenza A occurred in the vaccinated group as compared to the controls. The incidence of influenza in the control groups was between 25 and 43 per cent as compared to 13 to 15 per cent in those inoculated. These observations suggest that a measure of protection was afforded by vaccination but do not permit the conclusion that efficient protection resulted.
